Side-by-side financials for CTNM and LLY. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CTNM | LLY |
|---|---|---|
| Market cap | - | $1.072 T |
| US-listed rank | - | #10 |
| Revenue (latest FY) | $0.00 | $65.18B |
| Net income (latest FY) | -$59.98M | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 156 | 989 |
In their latest fiscal years, Contineum Therapeutics, Inc. reported $0.00 in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Contineum Therapeutics, Inc. and ELI LILLY & Co, or browse the full rankings.